Very early researchUnknownNCT04565197What this trial is testingConvalescent Plasma Therapy for COVID-19 PatientsWho this might be right forSARS-CoV Infection Lahore General Hospital 20
Large-scale testing (Phase 3)UnknownNCT04395170What this trial is testingConvalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.Who this might be right forCoronavirus Disease 2019 (COVID-19) Lifefactors Zona Franca, SAS 75
Testing effectiveness (Phase 2)Study completedNCT04389710What this trial is testingConvalescent Plasma for the Treatment of COVID-19Who this might be right forCOVID-19 Thomas Jefferson University 52
Not applicableStudy completedNCT04973488What this trial is testingTherapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 PatientsWho this might be right forCOVID-19 PneumoniaCOVID-19 Respiratory InfectionAcute Respiratory Failure+1 more Novacescu Alexandru 38
Testing effectiveness (Phase 2)Study completedNCT04373460What this trial is testingConvalescent Plasma to Limit SARS-CoV-2 Associated ComplicationsWho this might be right forSARS-CoV 2 Johns Hopkins University 1,225
Early research (Phase 1)UnknownNCT04474340What this trial is testingCOVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected PatientsWho this might be right forModerate COVID-19 Pneumonia, Severe COVID-19 PneumoniaPneumonia, Viral Ministry of Health, Kuwait 300
Not applicableStudy completedNCT04356534What this trial is testingConvalescent Plasma Trial in COVID -19 PatientsWho this might be right forSARS-CoV 2COVID-19 Royal College of Surgeons in Ireland - Medical University of Bahrain 40
Testing effectiveness (Phase 2)Study completedNCT04385199What this trial is testingConvalescent Plasma for Patients With COVID-19Who this might be right forCoronavirus InfectionCoronavirusCOVID Henry Ford Health System 30
Testing effectiveness (Phase 2)UnknownNCT04712344What this trial is testingAssessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO)Who this might be right forSevere COVID-19 University of Erlangen-Nürnberg Medical School 58
Large-scale testing (Phase 3)UnknownNCT04385043What this trial is testingHyperimmune Plasma in Patients With COVID-19 Severe InfectionWho this might be right forCOVID-19 University of Catanzaro 400
Testing effectiveness (Phase 2)WithdrawnNCT02190799What this trial is testingAnti-MERS-CoV Convalescent Plasma TherapyWho this might be right forRespiratory Distress Syndrome (& [Hyaline Membrane Disease]) King Abdullah International Medical Research Center
Early research (Phase 1)WithdrawnNCT04411602What this trial is testingIntermediate IND Severe Illness COVID-19 CPWho this might be right forSevere Acute Respiratory SyndromeCOVID Henry Ford Health System
Not applicableActive Not RecruitingNCT04497779What this trial is testingAnalysis of Coronavirus Disease 19 (COVID-19) Convalescent PlasmaWho this might be right forAsymptomatic COVID-19 Infection Laboratory-ConfirmedSymptomatic COVID-19 Infection Laboratory-Confirmed City of Hope Medical Center 95
Large-scale testing (Phase 3)Study completedNCT04649879What this trial is testingConvalescent Plasma for Treatment of COVID-19Who this might be right forCovid19 Joakim Dillner 59
Testing effectiveness (Phase 2)Study completedNCT04405310What this trial is testingConvalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center TrialWho this might be right forSARS Pneumonia Grupo Mexicano para el Estudio de la Medicina Intensiva 42
Not applicableStudy completedNCT04397523What this trial is testingEfficacy and Safety of COVID-19 Convalescent PlasmaWho this might be right forConvalescent PlasmaCOVID-19SARS-CoV 2 Institute for Transfusion Medicine of RNM 200
Testing effectiveness (Phase 2)Study completedNCT04374565What this trial is testingConvalescent Plasma for Treatment of COVID-19 Patients With PneumoniaWho this might be right forCorona Virus InfectionSARS-CoV 2SARS Pneumonia+1 more University of Virginia 29
Testing effectiveness (Phase 2)Study completedNCT04621123What this trial is testingPlasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 PatientsWho this might be right forSARS-CoV-2 InfectionSafety and Efficacy Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 384
Large-scale testing (Phase 3)Study completedNCT04374526What this trial is testingEarly transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.Who this might be right forCoronavirus Disease 2019 )COVID-19) Fondazione Policlinico Universitario Agostino Gemelli IRCCS 29
Not applicableUnknownNCT02333578What this trial is testingClinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola TreatmentWho this might be right forEbola Virus Disease Clinical Research Management, Inc. 70